Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis.

These findings implicate immunosenescence and metabolism as novel targets for biomarkers and therapeutic discovery and suggest immunomodulation as an early intervention. The variance observed in the plasma proteomes may depend on different biological patterns of disease progression in human and animal model.